Synthesis and transport of creatine in the CNS: importance for cerebral functions.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms, deficiencies, and therapeutic potential without systematic search criteria.
PubMed 20796169 · doi:10.1111/j.1471-4159.2010.06935.x
What was done
The author conducted a narrative review examining literature on creatine metabolism and transport in the central nervous system. The review synthesized evidence regarding primary creatine deficiency syndromes (involving L-arginine:glycine amidinotransferase, guanidinoacetate methyltransferase, or the creatine transporter), blood-brain barrier permeability, endogenous cerebral creatine synthesis, potential neuromodulatory functions, and potential neuroprotective roles in neurodegenerative conditions such as Parkinson's and Huntington's diseases.
What was found
The abstract provides a qualitative summary and reports no quantitative numbers or statistical measures. It reports that creatine crosses the blood-brain barrier with poor efficiency, indicating the brain must satisfy part of its creatine needs via endogenous local synthesis. It also identifies the central nervous system as the main tissue impaired in primary creatine deficiency syndromes.
Why it matters
This review highlights the physiological constraints of systemic creatine entry into the brain, explaining why endogenous synthesis is vital and why central creatine deficiency syndromes present severe cerebral manifestations.
Limits
The abstract describes a narrative review without systematic search protocols, quantitative synthesis, or clinical effect sizes. Specific sample sizes, patient demographics, and empirical outcomes are not reported.
Cited by
- supports Circulating creatine has limited permeability and poorly crosses the blood-brain barrier.